VIVO Cannabis Inc. (TSX.V: VIVO) (OTCQX: VVCIF) this
morning announced receipt of local municipal approval for its wholly-owned
subsidiary, Canna Farms Limited, for its phase 5 expansion that will add to its
Hope, B.C. facility an incremental 2,500 kilograms of indoor capacity.
According to the update, the expansion, originally slated to begin construction
in 2020, is now, pending regulatory approval, expected to be completed in late
2019 or early 2020. The expansion, with expected capital costs of $3.5 million,
consists of 10,000 square feet of cultivation space and is expected to bring
VIVO’s total internal production capacity to 13,500 kilograms by early 2020.
“Canna Farms is a cultivator and purveyor of premium quality, award winning,
small-batch craft cannabis with widespread recognition and appeal as evidenced
by its award for ‘Top Reviewed Licensed Producer of the Year’ at the 2018
Canadian Cannabis Awards,” VIVO CEO Barry Fishman said in the news release.
“This expansion will further increase Canna Farms’ production capacity to help
meet the significant market demand for premium B.C. dry bud. This project
represents a strategic deployment of a minor portion of our strong cash
position as the Company continues to invest to drive future growth.”
To view the full press release, visit http://ibn.fm/QZkEM
About VIVO Cannabis(TM)
VIVO Cannabis(TM), based in Napanee, Ontario, is recognized
for trusted, high-quality products and services. It holds production and sales
licenses from Health Canada and operates world-class indoor cultivation
facilities with proprietary plant-growing technology. VIVO has a collection of
premium brands targeting unique customer segments, including Beacon
Medical(TM), FIRESIDE(TM), Canna Farms(TM) and Lumina(TM). In August 2018, VIVO
acquired Canna Farms, a premium cannabis company based in Hope, British
Columbia. Canna Farms was B.C.’s first Licensed Producer and has several years
of craft cultivation experience and expertise, as well as a significant patient
base and positive cash flow. The Company is significantly expanding its
production capacity and pursuing partnership and product development
opportunities domestically, as well as in select international markets,
including Germany and Australia. VIVO also operates Harvest Medicine, a
patient-centric and highly scalable network of specialty medical cannabis
clinics as well as a free telemedicine app. VIVO has a healthy balance sheet
and is well-positioned to accelerate its growth in Canada and internationally.
For more information, visit the company’s website at www.VivoCannabis.com.
NOTE TO INVESTORS: The latest news and updates
relating to VVCIF are available in the company’s newsroom at http://ibn.fm/VVCIF
About MissionIRNewsBreaks
MissionIRNewsBreaks provide
a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by
our Team of professional journalists that keep a constant eye on the markets,
these posts are designed to inform you on the latest happenings of our clients
and other publicly traded companies on our radar. From earnings, acquisitions
and agreements to conference attendance and clinical study results, our news
breaks keep you up-to-date with the day’s top movers. MissionIR is primarily
focused on strategic communications. We have executed countless communications
programs to address the needs of companies ranging from start-ups to
established industry leaders, gaining valuable experience and the expertise
necessary to determine the most effective strategy for any given situation.
Please see full terms of use and disclaimers on the Mission
Investor Relations website applicable to all content provided by MIR, wherever
published or re-published: http://www.missionir.com/disclaimer.html
